Get started
Author

Ali Tarhini

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
2018 · Joseph Sleiman, Ali Tarhini, et al. · International Journal of Molecular Sciences · 84
PDF
Renal Complications in Thalassemia
2018 · Joseph Sleiman, Ali Tarhini, et al. · Thalassemia Reports · 19
PDF
GLP1 receptor agonists and SGLT2 inhibitors for the prevention or delay of type 2 diabetes mellitus onset: a systematic review and meta-analysis
2025 · Farah Ghobar, Ali Tarhini, et al. · Frontiers in Endocrinology · 6
PDF
Idiopathic Granulomatous Mastitis, Erythema Nodosum, and Polyarthritis
2024 · Ali Tarhini, Georges El Hasbani, et al. · Clinical Medicine Insights Arthritis and Musculoskeletal Disorders · 2
Short-term cardiotoxicity and early echocardiographic changes following autologous hematopoietic stem cell transplantation: a single-center retrospective analysis
2026 · Jean El Cheikh, Maria El Tannir, et al. · Frontiers in Cardiovascular Medicine · 1
PDF
Host Determinants of Immune Checkpoint Inhibitor Efficacy: Immune, Genetic, Metabolic, and Lifestyle Factors
2026 · Ali Awada, Nicole Charbel, et al. · International Journal of Molecular Sciences · 1
PDF
IBCL-763: Chameleon Cancer: Unraveling an Extraordinary Case of a Non-Hodgkin Lymphoma (NHL) With Multiple Transformations
2025 · Ali Tarhini, Andrea Issa, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Perceptions, knowledge, and attitudes toward do-not-resuscitate (DNR) and do-not-intubate (DNI) orders among caregivers of cancer patients in Lebanon: A cross-sectional study.
2026 · Nicole Charbel, Akel Khaled, et al. · JCO Oncology Practice
PDF
Toxicity attribution during enfortumab vedotin plus pembrolizumab therapy in urothelial carcinoma: a practical framework
2026 · Jabra Zarka, Daniel S Childs, et al. · The Oncologist
Therapeutic Resistance in Melanoma: Molecular Mechanisms and Emerging Pharmaceutical Strategies
2026 · Nicolas Moussallem, Ali Awada, et al. · Pharmaceuticals
Cardiovascular Toxicities of Contemporary Cancer Immunotherapies: A Narrative Review of Immune Checkpoint Inhibitors, Bispecific T-Cell Engagers, and CAR-T Cell Therapies
2026 · Jean El Cheikh, Bahaa El Deen Wehbeh, et al. · Clinical Lymphoma Myeloma & Leukemia
Total body irradiation across conditioning intensities: historical context, dose–fractionation strategy, and the role of the chemotherapy backbone
2026 · Jean El Cheikh, Maria El Tannir, et al. · Bone Marrow Transplantation
Thrombotic complications in patients treated with immune checkpoint inhibitors: a retrospective study of incidence, risk factors, and survival outcomes
2026 · Ali Awada, Ali Ghais, et al. · Frontiers in Immunology
PDF
ALL-1391: Real-World Later-Line Use of Asciminib in Philadelphia-Positive Acute Lymphoblastic Leukemia
2026 · Ali Tarhini, Husnain Ali, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-1413: Acute Myeloid Leukemia Treatment in Patients With Advanced Chronic Kidney Disease
2026 · Ali Tarhini, Husnain Ali, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: CT-990: Prognostic Impact of 8-Locus HLA Matching in Haploidentical Hematopoietic Stem Cell Transplantation: A Single Center Study
2026 · Ali Tarhini, Ali Awada, et al. · Clinical Lymphoma Myeloma & Leukemia
CT-990: Prognostic Impact of 8-Locus HLA Matching in Haploidentical Hematopoietic Stem Cell Transplantation: A Single Center Study
2026 · Ali Tarhini, Ali Awada, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: CT-1003: Antibiotic Escalation and Early Infectious Complications Following Antithymocyte Globulin and Posttransplant Cyclophosphamide–Based Haploidentical Stem Cell Transplantation
2026 · Sally Chahine, Ali Tarhini, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-1413: Acute Myeloid Leukemia Treatment in Patients With Advanced Chronic Kidney Disease
2026 · Ali Tarhini, Husnain Ali, et al. · Clinical Lymphoma Myeloma & Leukemia
CT-1003: Antibiotic Escalation and Early Infectious Complications Following Antithymocyte Globulin and Posttransplant Cyclophosphamide–Based Haploidentical Stem Cell Transplantation
2026 · Sally Chahine, Ali Tarhini, et al. · Clinical Lymphoma Myeloma & Leukemia
Organ–System Predictors of Immune–Related Adverse Events and Their Prognostic Impact in Immune Checkpoint Inhibitors–Treated Cancer Patients: A MENA Retrospective Cohort
2026 · Ali Awada, Ali Tarhini, et al. · Cancers
Artificial intelligence for optimization of immunotherapy: current applications and transformative potential
2026 · Ali Tarhini, Palak Dave, et al. · Frontiers in Immunology
PDF
Thrombotic events in patients receiving immune checkpoint inhibitors: Incidence, risk factors, and prognostic outcomes from a retrospective cohort study.
2026 · Ali Awada, Ali Ghais, et al. · Journal of Clinical Oncology
Clinicopathological predictors of survival and disease progression in melanoma: A real-world cohort from the MENA region.
2026 · Rani Hassan, Ali Awada, et al. · Journal of Clinical Oncology
Evolution of symptom burden across prostate cancer disease states in the EHR-facilitated Cancer Symptom Control (E2C2) trial.
2026 · Ali Tarhini, Miguel Muniz, et al. · Journal of Clinical Oncology
Works count: 41
Citation count: 114
H-index: 3
I10-index: 2
Year
Topic
Type